Nieuwe IMI oproep

IMI has now launched its 11th Call for proposals with the following topics:

  • Applied public-private research enabling osteoarthritis clinical headway
  • European platform for proof of concept for prevention in Alzheimer’s disease
  • Blood-based biomarker assays for personalised tumour therapy: value of latest circulating biomarkers
  • Zoonoses anticipation and preparedness initiative
  • Generation of research tools to translate genomic discoveries into drug discovery projects
  • EcoRiskPrediction

Topics under the New Drugs for Bad Bugs (ND4BB) programme on antimicrobial resistance:

  • Epidemiology research and development of novel systemic antibacterial molecules against healthcare-associated infections due to Gram-negative pathogens
  • Subtopic: Epidemiology research and clinical development of a novel bispecific IgG antibody, Bis4αPA, for the prevention of serious Pseudomonas aeruginosa disease
  • Subtopic: Clinical development of a novel resistance-breaking beta-lactam antibiotic, AIC499, in combination with a beta-lactamase inhibitor (BLI) against severe bacterial infections due to Gram-negative pathogens
  • Development of novel inhaled antibiotic regimens in patients with cystic fibrosis (CF) and patients with non-CF bronchiectasis (BE)

Deadline for submitting Expressions of Interest (EoIs)
8 April 2014

Geef een reactie

Je e-mailadres zal niet getoond worden. Vereiste velden zijn gemarkeerd met *